| AF | atrial fibrillation |
| AKI | acute kidney injury |
| BMI | body mass index |
| CAD | coronary artery disease |
| CKD | chronic kidney disease |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
| eGFR | estimated glomerular filtration rate |
| ESRD | end-stage renal disease |
| HbA1c | hemoglobin A1c |
| INR | international normalized ratio |
| LDL | low-density lipoprotein |
| LVEF | left ventricular ejection fraction |
| NOACs | non-vitamin K antagonist oral anticoagulants |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| NVAF | nonvalvular atrial fibrillation |
| PAR | protease-activated receptor |
| RAAS inhibitors | renin–angiotensin–aldosterone system inhibitors |
| SBP | systolic blood pressure |
| SCr | serum creatinine |
| SEE | systemic embolism event |
| SGLT-2 inhibitors | sodium-glucose cotransporter-2 inhibitors |
| TTR | time in therapeutic range |
| VKAs | vitamin K antagonists |
| WRN | warfarin-related nephropathy |